References
- Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;34:12–17.
- Lambrot R, Coffigny H, Pairault C, et al. High radiosensitivity of germ cells in human male fetus. J Clin Endocrinol Metab 2007;92:2632–9.
- Shen HM, Chia SE, Ong CN. Evaluation of oxidative DNA damage in human sperm and its association with male infertility. J Androl 1999;20:718–23.
- Kim JS, Heo K, Yi JM, et al. Genistein mitigates radiation-induced testicular injury. Phytother Res 2012;26:1119–25.
- Kovacs GT, Stern K. Reproductive aspects of cancer treatment: an update. Med J Aust 1999;170:495–7.
- Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol 2013;19:199–208.
- Albadainah F, Khader J, Salah S, Salem A. Choroidal metastasis secondary to prostatic adenocarcinoma: case report and review of literature. Hematol Oncol Stem Cell Ther 2013; Epub ahead of print.
- Jacobsen KD, Olsen DR, Fosså K, Fosså SD. External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 1997;38:95–102.
- Joos H, Sedlmayer F, Gomahr A, et al. Endocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalities. Radiother Oncol 1997;43:159–62.
- Cionini L, Ciatto S, Pirtoli L, Santoni R, Cappellini M. Radiotherapy of seminoma of the testis. Report on 129 patients. Tumori 1978;64:183–92.
- Fosså SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989;16:383–8.
- Spyropoulou D, Kardamakis D. Review of hypofractionated radiotherapy for prostate cancer. ISRN Oncol 2012;2012:410892.
- Loblaw DA, Cheung P. External beam irradiation for localized prostate cancer—the promise of hypofractionation. Can J Urol 2006;13:62–6.
- Chan EK, Woods R, Virani S, et al. Long-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancer. Radiother Oncol 2014; Epub ahead of print.
- Tjessem KH, Johansen S, Malinen E, et al. Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys 2013;87:337–43.
- Arcangeli G, Fowler J, Gomellini S, et al. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2011;79:1013–21.
- Yau I, Vuong T, Garant A, et al. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer. Int J Radiat Oncol Biol Phys 2009;74:1481–6.
- Cummings BJ, Rider WD, Harwood AR, et al. Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis Colon Rectum 1983;26:30–6.
- Sun J, Sun YH, Zeng ZC, et al. Consideration of the role of radiotherapy for abdominal lymph node metastases in patients with recurrent gastric cancer. Int J Radiat Oncol Biol Phys 2010;77:384–91.
- Willett CG. The role of radiation therapy and 5-fluorouracil in colon and rectal cancer. Semin Radiat Oncol 1997;7:300–5.
- Mulcahy N. AUA and ASTRO issue joint guidelines for postsurgery radiotherapy. Medscape Medical News. 2013. http://www.medscape.com/viewarticle/803942. Accessed 23 May 2013.
- Thompson IM, Valicenti R, Albertsen PC. Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline. American Urological Association. http://www.auanet.org/education/guidelines/radiation-after-prostatectomy.cfm. Accessed 23 May 2013.
- Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006;13:508–17.
- Gong EJ, Shin IS, Son TG, Yang K, Heo K, Kim JS. Low-dose-rate radiation exposure leads to testicular damage with decreases in DNMT1 and HDAC1 in the murine testis. J Radiat Res 2014;55:54–60.
- King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JCJr. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009;73:1043–8.
- Kinsella TJ. Effects of radiation therapy and chemotherapy on testicular function. Prog Clin Biol Res 1989;302:157–71.
- Kim RY, McGinnis LS, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: potential geographic miss and its impact on pelvic control. Int J Radiat Oncol Biol Phys 1995;31:109–12.
- Samanta N, Goel HC. Protection against radiation induced damage to spermatogenesis by Podophyllum hexandrum. J Ethnopharmacol 2002;81:217–24.
- Zhang H, Zheng RL, Wei ZQ, et al. Effects of pre-exposure of mouse testis with low-dose (16)O8+ ions or 60Co gamma-rays on sperm shape abnormalities, lipid peroxidation and superoxide dismutase (SOD) activity induced by subsequent high-dose irradiation. Int J Radiat Biol 1998;73:163–7.
- Budgell GJ, Cowan RA, Hounsell AR. Prediction of scattered dose to the testes in abdominopelvic radiotherapy. Clin Oncol (R Coll Radiol) 2001;13:120–5.